GlassScriptPhysician profile
Kim Ray Shrum
NPI 1902895568
$1,020.72
in general payments reported to CMS, 2019-2025
16 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2021: $183 · 2022: $126 · 2023: $282 · 2024: $174 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $249.19 | 2023-2025 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $135.01 | 2019-2024 | Clareon |
| Abbvie INC. | $106.67 | 2022-2025 | Lumigan, Vuity, Alphagan P |
| Johnson & Johnson Vision Care, INC. | $103.51 | 2021-2023 | Acuvue |
| Allergan, INC. | $75.45 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $50.69 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $48.32 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $44.25 | 2023-2024 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $38.12 | 2022-2024 | Infuse |
| Dompe US, INC. | $32.07 | 2025 | Oxervate |
| Shire North American Group INC | $30.94 | 2019 | |
| Sun Pharmaceutical Industries INC. | $26.49 | 2019 | |
| Aerie Pharmaceuticals, INC. | $21.21 | 2021 | |
| Rxsight INC | $20.49 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Johnson & Johnson Surgical Vision, INC. | $19.75 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Shrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.